| Authors: |
Fan W; Department of Nuclear Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Li Y; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China., Shi H; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China., Guo J; Department of Urology, Fudan University Zhongshan Hospital, Shanghai, China., Huang R; Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China., Dong Q; Department of Urology, West China Hospital, Sichuan University, Chengdu, China., Yang Z; Department of Nuclear Medicine, Peking University Cancer Hospital, Beijing, China., Yang Y; Department of Urology, Peking University Cancer Hospital, Beijing, China., Wang X; Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Gu D; Department of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Ye D; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China., Wang F; Department of Nuclear Medicine, Nanjing First Hospital, Nanjing, China., Wang J; Department of Nuclear Medicine, Xijing Hospital, Xi'an, China., Xu D; Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Jiang Z; Novartis Biomedical Research, Shanghai, China., Li H; Novartis Development, Beijing, China., Li J; Novartis Development, Shanghai, China., Li R; Novartis Pharmaceuticals Corporation, Shanghai, China., Huo L; Peking Union Medical College Hospital, Beijing, China., Ji Z; Peking Union Medical College Hospital, Beijing, China. |
